0001209191-23-036149.txt : 20230612 0001209191-23-036149.hdr.sgml : 20230612 20230612090359 ACCESSION NUMBER: 0001209191-23-036149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230608 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eichenfield Lawrence CENTRAL INDEX KEY: 0001814892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38529 FILM NUMBER: 231007215 MAIL ADDRESS: STREET 1: C/O FORTE BIOSCIENCES, INC. STREET 2: 1124 W. CARSON ST., MRL BLDG 3-320 CITY: TORRANCE STATE: CA ZIP: 90502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660334 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463137900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 NORTH HIGH STREET STREET 2: SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 484-453-3300 MAIL ADDRESS: STREET 1: 10 NORTH HIGH STREET STREET 2: SUITE 200 CITY: WEST CHESTER STATE: PA ZIP: 19380 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-08 0 0001660334 Verrica Pharmaceuticals Inc. VRCA 0001814892 Eichenfield Lawrence C/O VERRICA PHARMACEUTICALS INC. 44 WEST GAY STREET, SUITE 400 WEST CHESTER PA 19380 1 0 0 0 0 Stock Option (right to buy) 5.70 2023-06-08 4 A 0 10384 0.00 A 2033-06-07 Common Stock 10384 10384 D The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 8, 2023 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date. /s/ Mark Ballantyne, Attorney-in-Fact 2023-06-12